Dr. Hönle AG Cash Flow Conversion Efficiency
Dr. Hönle AG cash flow conversion efficiency. Based on the latest financial reports, Dr. Hönle AG (HNL) has a cash flow conversion efficiency ratio of 0.029x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€2.20 Million ≈ $2.57 Million USD) by net assets (€76.06 Million ≈ $88.93 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Dr. Hönle AG (2014–2025)
Cash flow conversion efficiency of Dr. Hönle AG from 2014 to 2025. This chart illustrates how Dr. Hönle AG's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Dr. Hönle AG (HNL) share price today for real-time trading data and today's change.
Dr. Hönle AG Cash Flow Conversion Ratio Explained
Dr. Hönle AG cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Dr. Hönle AG Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Dr. Hönle AG ranked by their cash flow conversion efficiency. Also see Dr. Hönle AG market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shin Tai Industry Co Ltd
TW:1235
|
0.002x |
|
PJ Electronics Co. Ltd
KQ:006140
|
-0.072x |
|
Ckd Bio
KO:063160
|
0.022x |
|
Tembaga Mulia Semanan Tbk
JK:TBMS
|
0.134x |
|
Lake Resources N.L.
AU:LKE
|
-0.064x |
|
Grove Collaborative Holdings, Inc.
NYSE:GROV
|
-0.093x |
|
GenMont Biotech Inc
TW:3164
|
0.011x |
|
Thomas Scott (India) Limited
NSE:THOMASCOTT
|
-0.146x |
Annual Cash Flow Conversion Efficiency for Dr. Hönle AG (2014–2025)
The table below shows the annual cash flow conversion efficiency of Dr. Hönle AG from 2014 to 2025. Review Dr. Hönle AG free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | €77.03 Million ≈ $90.06 Million |
€4.99 Million ≈ $5.83 Million |
0.065x | -6.73% |
| 2024-09-30 | €79.69 Million ≈ $93.16 Million |
€5.53 Million ≈ $6.47 Million |
0.069x | +112.26% |
| 2023-09-30 | €96.13 Million ≈ $112.39 Million |
€3.14 Million ≈ $3.67 Million |
0.033x | +147.34% |
| 2022-09-30 | €107.24 Million ≈ $125.37 Million |
€-7.41 Million ≈ $-8.66 Million |
-0.069x | -779.14% |
| 2021-09-30 | €111.12 Million ≈ $129.91 Million |
€1.13 Million ≈ $1.32 Million |
0.010x | -83.60% |
| 2020-09-30 | €116.69 Million ≈ $136.42 Million |
€7.23 Million ≈ $8.46 Million |
0.062x | -66.99% |
| 2019-09-30 | €90.12 Million ≈ $105.36 Million |
€16.92 Million ≈ $19.79 Million |
0.188x | -32.34% |
| 2018-09-30 | €87.25 Million ≈ $102.00 Million |
€24.22 Million ≈ $28.31 Million |
0.278x | +194.37% |
| 2017-09-30 | €69.78 Million ≈ $81.58 Million |
€6.58 Million ≈ $7.69 Million |
0.094x | -32.66% |
| 2016-09-30 | €61.67 Million ≈ $72.10 Million |
€8.63 Million ≈ $10.09 Million |
0.140x | -12.08% |
| 2015-09-30 | €57.51 Million ≈ $67.24 Million |
€9.16 Million ≈ $10.71 Million |
0.159x | +5.68% |
| 2014-09-30 | €49.72 Million ≈ $58.13 Million |
€7.49 Million ≈ $8.76 Million |
0.151x | -- |
About Dr. Hönle AG
Hoenle AG develops, manufactures, and distributes industrial UV technologies and systems in Germany and internationally. It operates through three segments: Adhesive Systems, Curing, and Disinfection. The Adhesives Systems segment offers industrial adhesives, as well as supplies adhesive curing systems used for consumer electronics, automotive, optics and opto-electronics, and curing of adhesives… Read more